Literature DB >> 8736420

The relationship between severity of coronary artery disease and vital exhaustion.

W J Kop1, A P Appels, C F Mendes de Leon, F W Bär.   

Abstract

The present study investigates the association between the severity of coronary artery disease (CAD) and feelings of exhaustion. Vital exhaustion consists of three major components: lack of energy, increased irritability, and demoralization. Previous studies showed that exhaustion is of predictive value for first myocardial infarction (MI). However, these studies could not rule out that the state of exhaustion prior to MI was the result of underlying CAD. To examine this issue, severity of CAD and cardiac pump function were related to feelings of exhaustion in 307 patients who underwent coronary angiography. It was found that exhaustion, as assessed by means of the Maastricht Questionnaire (MQ), was not related to the severity of CAD (F = 1.17; p = 1.05). Furthermore, a poor left ventricular function did not relate to MQ scores (N = 138; F < 1; NS). On the other hand, clinical variables (duration of complaints, exercise performance, peripheral vascular disease, and dyspnea), use of medication (nitrates, beta-blocking agents, calcium antagonists, and diuretics), and demographic characteristics (gender and education) were associated with MQ scores. Multiple regression analysis showed that demographic variables (lower education, younger age, and female gender) were the predominant predictors of exhaustion. In addition, dyspnea, peripheral vascular disease, and the use of medication related significantly to exhaustion scores (R2 = 0.13; F = 4.8; p < 0.001). We conclude that neither the extent of CAD nor impaired cardiac pump function is related to feelings of exhaustion in patients referred for coronary angiography. Therefore, the previously reported association between exhaustion and future MI is not likely to be caused by underlying coronary disease.

Entities:  

Mesh:

Year:  1996        PMID: 8736420     DOI: 10.1016/0022-3999(95)00613-3

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  7 in total

1.  Vital exhaustion as a risk factor of myocardial infarction: a case-control study in Venezuela.

Authors:  N Bages; A Appels; P R Falger
Journal:  Int J Behav Med       Date:  1999

2.  Adverse psychological outcome in women with coronary artery disease.

Authors:  S S Pedersen; E Boersma; C G Jansen; J W Deckers; R A M Erdman
Journal:  Neth Heart J       Date:  2001-12       Impact factor: 2.380

3.  Clinical and socio-demographic predictors of postoperative vital exhaustion in patients after cardiac surgery.

Authors:  Pamela S Miller; Lorraine S Evangelista; Joyce Newman Giger; Kathleen Dracup; Lynn V Doering
Journal:  Heart Lung       Date:  2013 Mar-Apr       Impact factor: 2.210

4.  A prospective study into change of vitamin D levels, depression and frailty among depressed older persons.

Authors:  Karen S van den Berg; Johanna M Hegeman; Rob H S van den Brink; Didi Rhebergen; Richard C Oude Voshaar; Radboud M Marijnissen
Journal:  Int J Geriatr Psychiatry       Date:  2021-02-25       Impact factor: 3.485

5.  Self-rated health, life-style, and psychoendocrine measures of stress in healthy adult women.

Authors:  Christina Halford; Lisa Ekselius; Ingrid Anderzen; Bengt Arnetz; Kurt Svärdsudd
Journal:  Ups J Med Sci       Date:  2010-11       Impact factor: 2.384

6.  Accumulation of advanced glycation end products evaluated by skin autofluorescence and incident frailty in older adults from the Bordeaux Three-City cohort.

Authors:  Sophie Pilleron; Kalina Rajaobelina; Maturin Tabue Teguo; Jean-François Dartigues; Catherine Helmer; Cécile Delcourt; Vincent Rigalleau; Catherine Féart
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

7.  Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective cohort study (FLAGSHIP).

Authors:  Sumio Yamada; Takuji Adachi; Hideo Izawa; Toyoaki Murohara; Takaaki Kondo
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-09-30       Impact factor: 12.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.